RVTY Revvity, Inc.

151.59USD-0.55%Mkt Cap: 16.92B USDP/E: 67.37

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, and training and s…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap16.92B USD
Enterprise Value19.19B USD
Revenue (TTM)2.94B USD
Gross Profit1.56B USD
Net Income (TTM)241.20M USD
Revenue/Share26.26 USD
Last Price151.59 USD
Fiscal Year EndDec 2025
MR QuarterOct 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)67.37
P/E (Forward)25.45
PEG0.94
EV/EBITDA21.25
EV/Revenue6.52
P/S5.75
P/B2.33
EPS (TTM)2.25 USD
EPS (Forward)5.96 USD
52W Range
81.2278% of range171.74
52W High171.74 USD
52W Low81.22 USD
Profitability
Gross Margin54.77%
Oper. Margin16.66%
EBITDA Margin30.70%
Profit Margin8.45%
ROE3.33%
ROA1.98%
ROIC3.28%
ROCE3.29%
Growth
Revenue Growth4.30%
Earnings Growth37.80%
Cash Flow & Leverage
Operating CF582.93M USD
CapEx (TTM)73.52M USD
FCF Margin21.50%
FCF Yield3.74%
Net Debt2.17B USD
Net Debt/EBITDA2.40
Net Debt/FCF3.43
Balance Sheet
Debt/Equity0.47
Current Ratio2.65
Quick Ratio1.82
Book Value/Sh65.14 USD
Cash/Share5.31 USD
Dividends
Fwd Div Rate0.28 USD
Trail. Div Rate0.28 USD
Div. Yield0.18%
5Y Avg Yield0.23%
Payout Ratio12.44%
Ex-Div DateJan 22, 2027
Pay DateFeb 12, 2027
Splits
Last Split2:1
Split DateJun 4, 2001
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)171.40 USD
Upside (mean)+13.1%
Target Range122.00 USD – 200.00 USD
122.00+13.1% to mean200.00
# Analysts15
Ownership
Shares Out.111.64M
Float102.54M
Insiders0.26%
Institutions102.71%
Short Interest
Short Ratio3.5d
Short % Float8.76%
Short % Out.5.85%
Shares Short6.53M
Short (prev mo.)6.30M
Technical
SMA 50150.77 (+0.5%)
SMA 200114.23 (+32.7%)
Beta1.09
S&P 52W Chg12.08%
Avg Vol (30d)1.71M
Avg Vol (10d)1.85M
Technical Indicators
RSI (14)47.1
MACD-0.2399
MACD Signal1.1803
MACD Hist.-1.4201
BB Upper167.56 USD
BB Middle156.99 USD
BB Lower146.41 USD
BB Width13.48%
ATR (14)6.963 USD
Vol Ratio (20d)0.65x

About Revvity (NYSE: RVTY)

›

Revvity (NYSE: RVTY) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 11,000 employees.

The shares were at 151.59 USD on 19 November 2026, up 63.7% over 52 weeks. Its 52-week range is 81.22 USD to 171.74 USD: the price is 11.7% below the high and 86.6% above the low.

At a market capitalisation of 16.92B USD, it trades at 67.4 times trailing earnings and 25.5 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 34.9, a premium of 93% for RVTY. It pays a dividend yielding 0.18% (it pays out 12% of its earnings), against a median of 0.77% among the dividend payers in that peer group.

Revvity reports return on equity of 3.3%, an operating margin of 16.7% and revenue up 4.3% year over year.

Its debt exceeds its cash by 2.17B USD, a debt-to-equity ratio of 0.47. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 15 analysts cover the stock, with an average rating of Buy; their mean price target of 171.40 USD is 13.1% above the current price. The next earnings report is expected on 1 February 2027.